These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 36608868)
1. RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC. Cao Y; Di X; Cong S; Tian C; Wang Y; Jin X; Zhao M; Zhou X; Li R; Wang K Life Sci; 2023 Feb; 315():121359. PubMed ID: 36608868 [TBL] [Abstract][Full Text] [Related]
2. m Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312 [TBL] [Abstract][Full Text] [Related]
3. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Tang Y; Xiao G; Chen Y; Deng Y Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897 [TBL] [Abstract][Full Text] [Related]
4. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of Lung Cancer]. Zhang Y; Wang Y; Liu M Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978 [TBL] [Abstract][Full Text] [Related]
5. METTL3-Mediated m Mao Y; Li W; Weng Y; Hua B; Gu X; Lu C; Xu B; Xu H; Wang Z Cell Transplant; 2022; 31():9636897221122997. PubMed ID: 36073002 [TBL] [Abstract][Full Text] [Related]
6. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression. Li D; Fu Z; Dong C; Song Y Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574 [TBL] [Abstract][Full Text] [Related]
7. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer. Li S; Jiang F; Chen F; Deng Y; Pan X J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205 [TBL] [Abstract][Full Text] [Related]
8. METTL3 Mediated MALAT1 m6A Modification Promotes Proliferation and Metastasis in Osteosarcoma Cells. Zhang Y; Xu Y; Qiu G; Luo Y; Bao Y; Lu J; Wang T; Wang Y Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37897586 [TBL] [Abstract][Full Text] [Related]
9. RBM10 regulates alternative splicing of lncRNA Neat1 to inhibit the invasion and metastasis of NSCLC. Cong S; Di X; Li R; Cao Y; Jin X; Tian C; Zhao M; Wang K Cancer Cell Int; 2022 Nov; 22(1):338. PubMed ID: 36335386 [TBL] [Abstract][Full Text] [Related]
10. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis. Zhao C; Ling X; Xia Y; Yan B; Guan Q Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065 [TBL] [Abstract][Full Text] [Related]
11. METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation. Lin C; Li T; Wang Y; Lai S; Huang Y; Guo Z; Zhang X; Weng S Cell Death Dis; 2023 Mar; 14(3):221. PubMed ID: 36977668 [TBL] [Abstract][Full Text] [Related]
12. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway. Cui S J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887 [TBL] [Abstract][Full Text] [Related]
13. Methyltransferase-like 3 promotes the progression of lung cancer via activating PI3K/AKT/mTOR pathway. Cheng FW; Peng LM; Luo D Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):748-758. PubMed ID: 35434840 [TBL] [Abstract][Full Text] [Related]
14. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway. Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058 [TBL] [Abstract][Full Text] [Related]
15. METTL3-mediated m6A modification of EPPK1 to promote the development of esophageal cancer through regulating the PI3K/AKT pathway. Jia J; Yu L Environ Toxicol; 2024 May; 39(5):2830-2841. PubMed ID: 38293837 [TBL] [Abstract][Full Text] [Related]
16. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way. Dou X; Wang Z; Lu W; Miao L; Zhao Y BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805 [TBL] [Abstract][Full Text] [Related]
17. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway. Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer. Song J; Su ZZ; Shen QM Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554 [TBL] [Abstract][Full Text] [Related]
19. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis. Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899 [TBL] [Abstract][Full Text] [Related]
20. ROR1-AS1 knockdown inhibits growth and invasion and promotes apoptosis in NSCLC cells by suppression of the PI3K/Akt/mTOR pathway. Li F; Gu F; Li Q; Zhai C; Gong R; Zhu X J Biochem Mol Toxicol; 2021 May; 35(5):e22726. PubMed ID: 33491326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]